Efficacy and Safety of DWC202404 and DWC202314 in Patients With Hypertension

Clinical trial NCT06682000 · COMPLETED

Trial details

NCT number: NCT06682000
Sponsor: Daewoong Pharmaceutical Co. LTD.
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Hypertension Essential Hypertension

Start date: 2025-01-20
Primary completion: 2025-10-02
Enrollment: 192

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.